Monthly Archives: February 2017

  • 0

“The Future of (Bio)Pharmaceutical Manufacturing” February 28th, Brussels

Elaine Harris will attend this high level seminar whose objective is to bring together policy- and decision-makers, industry R&D and academia, and other relevant stakeholder organizations in order to discuss a roadmap for innovation in (bio)pharmaceutical manufacturing. Attendees and speakers will include Barry Heavey (IDA), Rainer Fischer (Fraunhofer IME), Sean Kelly MEP, Mark Ferguson (Chief Science Advisor to the Government of Ireland), Seamus Malone (Eli Lilly),Yvonne Van Megan (Janssen Biologics B.V.), Padraig Somers (Helsinn), Ian Jones (Innopharma Labs)
http://iscintelligence.com/event.php?id=311


  • 0

Negotiating the maze of Innovation Funding supports in Ireland

Category : Uncategorized

Brendan Lawlor recently presented an overview of the various funding supports (EI/ IDA/ SFI Schemes, R and D Tax schemes, Horizon 2020 and some lesser known schemes) available in Ireland. The presentation included tips on getting started and tips when applying for supports. If you would like a copy of the presentation please email Brendan (at) innovation21.ie.If you need any assistance with figuring out which is the most appropriate scheme for your companies R and D needs please contact Brendan or Elaine for an initial confidential discussion


  • 0

Multinationals delaying investment decisions due to Global political uncertainty

Category : Uncategorized

Martin Shanahan, CEO of the IDA, reported today that multinational companies are delaying investment decisions due to political uncertainty in the US and worldwide. He was speaking at the announcement of an additional 500 jobs being created by recruitment company Indeed


  • 0

Recent publication by E Harris on the use of social media for ADR reporting

Category : Publications

A recent publication in the Journal of Pharmacovigilance by Elaine Harris (Innovation 21) and Ishak Omar (Quintiles IMS) discusses the potential benefits of using social media for Adverse Drug Reaction (ADR) reporting. Results  from the study indicate that a collaborative effort is required between the pharmaceutical industry, HCPs and the public before social media can reach its full beneficial potential as a tool in Pharmacovigilance. https://www.esciencecentral.org/journals/the-use-of-social-media-in-adr-monitoring-and-reporting-2329-6887-1000223.php?aid=83486view=mobile


  • 0

IRDG R&D Tax Credit and Knowledge Development Box Seminar, Dublin – March 9th 2017

Category : Uncategorized

We will be attending the R and D Tax Credit Briefing run by the IRDG on March 9th

Full details here


Enjoy this blog? Please spread the word :)